Andrew M Clarkson - Net Worth and Insider Trading
Andrew M Clarkson Net Worth
The estimated net worth of Andrew M Clarkson is at least $22 Million dollars as of 2024-09-20. Andrew M Clarkson is the Director of Amphenol Corp and owns about 336,000 shares of Amphenol Corp (APH) stock worth over $22 Million. Andrew M Clarkson is also the Director of Oncternal Therapeutics Inc and owns about 102 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $162. Details can be seen in Andrew M Clarkson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew M Clarkson has not made any transactions after 2005-10-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew M Clarkson
Andrew M Clarkson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew M Clarkson owns 2 companies in total, including Oncternal Therapeutics Inc (ONCT) , and Amphenol Corp (APH) .
Click here to see the complete history of Andrew M Clarkson’s form 4 insider trades.
Insider Ownership Summary of Andrew M Clarkson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2005-10-11 | director |
| APH | Amphenol Corp | 2004-04-26 | director |
Andrew M Clarkson Latest Holdings Summary
Andrew M Clarkson currently owns a total of 2 stocks. Among these stocks, Andrew M Clarkson owns 336,000 shares of Amphenol Corp (APH) as of April 26, 2004, with a value of $22 Million and a weighting of 100%. Andrew M Clarkson also owns 102 shares of Oncternal Therapeutics Inc (ONCT) as of October 11, 2005, with a value of $162 and a weighting of 0%.
Latest Holdings of Andrew M Clarkson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APH | Amphenol Corp | 2004-04-26 | 336,000 | 65.46 | 21,994,560 |
| ONCT | Oncternal Therapeutics Inc | 2005-10-11 | 102 | 1.59 | 162 |
Holding Weightings of Andrew M Clarkson
Andrew M Clarkson Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew M Clarkson has made a total of 0 transactions in Amphenol Corp (APH) over the past 5 years. The most-recent trade in Amphenol Corp is the acquisition of 80,000 shares on April 26, 2004, which cost Andrew M Clarkson around $168,700.
According to the SEC Form 4 filings, Andrew M Clarkson has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 36 shares on October 11, 2005, which cost Andrew M Clarkson around $390,000.
Insider Trading History of Andrew M Clarkson
- 1
Andrew M Clarkson Trading Performance
GuruFocus tracks the stock performance after each of Andrew M Clarkson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew M Clarkson is -14.44%. GuruFocus also compares Andrew M Clarkson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew M Clarkson within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew M Clarkson's insider trading performs compared to the benchmark.
Performance of Andrew M Clarkson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.89 | | | | | |
| Relative Return to S&P 500(%) | 3.77 | | | | | |
Andrew M Clarkson Ownership Network
Andrew M Clarkson Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Andrew M Clarkson is the director of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Andrew M Clarkson made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Andrew M Clarkson Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew M Clarkson. You might contact Andrew M Clarkson via mailing address: P O Box 2198, Dept 8074, Memphis Tn 38101-9842.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
